According to government figures, 82 people died from drugs misuse in Surrey between 2020 and 2022. The former president says he offers "no apologies, no excuses" for his anti-crime campaign.
Kisqali (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4 ...
A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain high-risk breast cancer settings.
Drug related deaths have soared to a record high with deaths involving cocaine up by almost a third, worrying new figures have revealed. Some 5,448 deaths were linked to drug poisoning in England ...
(Office of the Special Narcotics Prosecutor in New York via AP) A recreational drug called “pink cocaine” is getting attention and causing confusion since it doesn’t typically contain cocaine. The ...
We are now in the era of weight-loss drugs. Decisions on how these drugs will be used look likely to shape our future health and even what our society might look like. And, as researchers are ...
Kisqali (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4 ...
People with asthma are often treated with a combination of quick-relief and long-term controller medicines. Quick-Relief Medicine works quickly to relax your airways and help you breathe easier. You ...
EMA's CHMP issued a positive opinion for Novartis' Kisqali for high-risk early breast cancer. Kisqali showed a 25.1% reduced risk of cancer recurrence in Phase 3 NATALEE trial. The CHMP ...
Novartis said the European Medicines Agency has recommended its Kisqali cancer drug for market authorization. The drugmaker said Friday that the EMA's Committee for Medicinal Products for Human ...
“If approved, Kisqali could provide an effective and tolerable adjuvant treatment option to mitigate the risk of recurrence in a broader patient population, particularly for patients who ...